Literature DB >> 351613

Cold pepsin digestion: a novel method to produce the Fv fragment from human immunoglobulin M.

L C Lin, F W Putnam.   

Abstract

A strategy for the proteolytic fragmentation of human IgM has been developed. This method is called "cold pepsin digestion" because of its unique feature of achieving restricted peptic cleavages at 4 degrees and pH 4.0. Cold pepsin digestion has been applied successfully to produce an Fv fragment from 14 human IgM proteins. The Fv fragment consists of the heavy chain variable domain (VH) and the light chain variable domain (VL) held together by strong noncovalent interaction. Thus, each Fv fragment contains one intact antigen-binding site and represents the minimal active fragment derivable from an antibody molecule. A series of other structurally and functionally important fragments were also isolated and characterized. Two basic digestion pathways were recognized; these mainly reflect the relative accessibility of five sets of major interdomain cleavage sites.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 351613      PMCID: PMC392620          DOI: 10.1073/pnas.75.6.2649

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  19 in total

1.  Structure of an antibody combining site by magnetic resonance.

Authors:  R A Dwek; S Wain-Hobson; S Dower; P Gettins; B Sutton; S J Perkins; D Givol
Journal:  Nature       Date:  1977-03-03       Impact factor: 49.962

2.  Binding of N-acetylgalactosamine-containing compounds by a human IgM paraprotein.

Authors:  M Naiki; D M Marcus
Journal:  J Immunol       Date:  1977-08       Impact factor: 5.422

3.  Binding of phosphorylcholine to an IgM Waldenström as studied by fluorescence spectroscopy and circular dichroism.

Authors:  W F Riesen; J Schlessinger; J C Jaton
Journal:  Biochemistry       Date:  1976-07-27       Impact factor: 3.162

4.  Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane.

Authors:  G Fairbanks; T L Steck; D F Wallach
Journal:  Biochemistry       Date:  1971-06-22       Impact factor: 3.162

5.  A Waldenström macroglobulin which binds nitrophenyl ligands.

Authors:  R F Ashman; H Metzger
Journal:  J Biol Chem       Date:  1969-06-25       Impact factor: 5.157

6.  The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.

Authors:  K Weber; M Osborn
Journal:  J Biol Chem       Date:  1969-08-25       Impact factor: 5.157

7.  Characterization of the Fv fragment isolated from a human immunoglobulin M.

Authors:  K Kakimoto; K Onoue
Journal:  J Immunol       Date:  1974-04       Impact factor: 5.422

8.  The switch point in mu heavy chains of human IgM immunoglobulins.

Authors:  G Florent; D Lehman; F W Putnam
Journal:  Biochemistry       Date:  1974-06-04       Impact factor: 3.162

9.  Bence-Jones proteins and light chains of immunoglobulins (second of two parts).

Authors:  A Solomon
Journal:  N Engl J Med       Date:  1976-01-08       Impact factor: 91.245

10.  Immunoglobulin M: pentameric Fcmu fragments released by trypsin at higher temperatures.

Authors:  A G Plaut; T B Tomasi
Journal:  Proc Natl Acad Sci U S A       Date:  1970-02       Impact factor: 11.205

View more
  9 in total

Review 1.  Biosynthetic antibody binding sites: development of a single-chain Fv model based on antidinitrophenol IgA myeloma MOPC 315.

Authors:  J E McCartney; L Lederman; E A Drier; N A Cabral-Denison; G M Wu; R S Batorsky; J S Huston; H Oppermann
Journal:  J Protein Chem       Date:  1991-12

2.  The 33,000 protein precipitated by Ly-6A.2-specific antibodies is not associated with the Ly-6 polymorphism.

Authors:  B A Houlden; I F McKenzie; P M Hogarth
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

3.  Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli.

Authors:  J S Huston; D Levinson; M Mudgett-Hunter; M S Tai; J Novotný; M N Margolies; R J Ridge; R E Bruccoleri; E Haber; R Crea
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

4.  Development of a sensitive radioimmunoassay for Fab fragments: application to Fab pharmacokinetics in humans.

Authors:  C V Thanh-Barthet; M Urtizberea; A E Sabouraud; N J Cano; J M Scherrmann
Journal:  Pharm Res       Date:  1993-05       Impact factor: 4.200

5.  Amino acid sequence of the Fv region of a human monoclonal IgM (protein WEA) with antibody activity against 3,4-pyruvylated galactose in Klebsiella polysaccharides K30 and K33.

Authors:  F Goñi; B Frangione
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

6.  Expression of immunoglobulin-cross-reactive molecules by neoplastic human T cells. I. Surface detection and isolation of molecules reactive with chicken anti-F(ab')2, anti-alpha and anti-mu antibodies.

Authors:  D G Haegert; M Timm
Journal:  Immunology       Date:  1983-11       Impact factor: 7.397

Review 7.  Antigen recognition and targeted delivery by the single-chain Fv.

Authors:  J S Huston; M S Tai; J McCartney; P Keck; H Oppermann
Journal:  Cell Biophys       Date:  1993 Jan-Jun

8.  Biochemical nature of an Fc mu receptor on human B-lineage cells.

Authors:  T Ohno; H Kubagawa; S K Sanders; M D Cooper
Journal:  J Exp Med       Date:  1990-10-01       Impact factor: 14.307

9.  Interfering with the high-affinity interaction between wheat amylase trypsin inhibitor CM3 and toll-like receptor 4: in silico and biosensor-based studies.

Authors:  Massimiliano Cuccioloni; Matteo Mozzicafreddo; Laura Bonfili; Valentina Cecarini; Mara Giangrossi; Maurizio Falconi; Shin-Ichiroh Saitoh; Anna Maria Eleuteri; Mauro Angeletti
Journal:  Sci Rep       Date:  2017-10-13       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.